Archives of Pediatric Infectious Diseases

Published by: Kowsar

Prevalence of Anti-Toxoplasma gondii Antibodies in Young Iranians: The CASPIAN III Study

Mohammad Javad Gharavi 1 , 2 , Mona Roozbehani 2 , Abolfazl Miahipour 3 , Mojgan Oshaghi 4 , Behnaz Gharegozlou 5 , Enayatollh Kalantar 6 , Shervin Ghaffari Hoseini 7 , Nasser Mostafavi 7 , Ramin Heshmat 8 , Abdolhossien Naseri 5 , Mostafa Qorbani 9 , 10 , * and Roya Kelishadi 11
Authors Information
1 Department of Medical Parasitology, Deputy of Researches and Technologies, Alborz University of Medical Sciences, Karaj, IR Iran
2 Department of Parasitology, School of Medicine, Iran university of medical sciences,Tehran, IR Iran
3 Department of Medical Parasitology and Mycology, School of Medicine, Alborz University of Medical Sciences, Karaj, IR Iran
4 Department of Microbiology, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, IR Iran
5 Department of Immunology, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, IR Iran
6 Department of Microbiology and Immunology, School of Medicine, Alborz University of Medical Sciences, Karaj, IR Iran
7 Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
8 Chronic Disease Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, IR Iran
9 Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, IR Iran
10 Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, IR Iran
11 Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, IR Iran
Article information
  • Archives of Pediatric Infectious Diseases: January 2018, 6 (1); e61640
  • Published Online: September 27, 2017
  • Article Type: Research Article
  • Received: October 1, 2016
  • Revised: March 25, 2017
  • Accepted: April 1, 2017
  • DOI: 10.5812/pedinfect.61640

To Cite: Gharavi M J, Roozbehani M, Miahipour A, Oshaghi M, Gharegozlou B, et al. Prevalence of Anti-Toxoplasma gondii Antibodies in Young Iranians: The CASPIAN III Study, Arch Pediatr Infect Dis. 2018 ; 6(1):e61640. doi: 10.5812/pedinfect.61640.

Copyright © 2017, Archives of Pediatric Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Furtado JM, Smith JR, Belfort RJ, Gattey D, Winthrop KL. Toxoplasmosis: a global threat. J Glob Infect Dis. 2011;3(3):281-4. doi: 10.4103/0974-777X.83536. [PubMed: 21887062].
  • 2. Boyle JP, Radke JR. A history of studies that examine the interactions of Toxoplasma with its host cell: Emphasis on in vitro models. Int J Parasitol. 2009;39(8):903-14. [PubMed: 19630139].
  • 3. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363(9425):1965-76. doi: 10.1016/S0140-6736(04)16412-X. [PubMed: 15194258].
  • 4. Dubey JP. Toxoplasmosis - a waterborne zoonosis. Vet Parasitol. 2004;126(1-2):57-72. doi: 10.1016/j.vetpar.2004.09.005. [PubMed: 15567579].
  • 5. Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39(12):1385-94. doi: 10.1016/j.ijpara.2009.04.003. [PubMed: 19433092].
  • 6. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30(12-13):1217-58. [PubMed: 11113252].
  • 7. Shahmoradi A, Rezaeian M, Dalimi ASLE A. Sheep-an important reservoir of human toxoplasmosis in iran. Med J Islamic Republic Iran. 1993;7(3):173-4.
  • 8. Jeannel D, Niel G, Costagliola D, Danis M, Traore BM, Gentilini M. Epidemiology of toxoplasmosis among pregnant women in the Paris area. Int J Epidemiol. 1988;17(3):595-602. [PubMed: 3264821].
  • 9. Ancelle T, Goulet V, Tirard-Fleury V, Baril L, Du Mazaubrun C, Thulliez PH, et al. La Toxoplasmose chez la femme enceinte en France en 1995. Resultats d’une enquete nationale perinatale. Bull Epidemiol Hebd. 1996;51:227-9.
  • 10. Schwartzman JD, Maguire JH. Tropical infectious diseases: principles, pathogens, and practice. In: Guerrant RC, Walker DH, Weller PF, editors. Philadelphia: Churchill Livingstone; 1999. Systemic coccidia (toxoplasmosis); p. 829-39.
  • 11. Onadeko MO, Joynson DH, Payne RA. The prevalence of Toxoplasma infection among pregnant women in Ibadan, Nigeria. J Trop Med Hyg. 1992;95(2):143-5. [PubMed: 1560485].
  • 12. Martin PA, Bouza PE. Infect Dis. In: Choen J, Powderly WG, editors. 2004. Blood and Tissue Protozoa; p. 2448-50.
  • 13. Rostami A, Keshavarz H, Shojaee S, Mohebali M, Meamar AR. Frequency of Toxoplasma gondii in HIV Positive Patients from West of Iran by ELISA and PCR. Iran J Parasitol. 2014;9(4):474-81. [PubMed: 25759728].
  • 14. Keshavarz H, Horri H. Prevalence of Toxoplasma gondii in pregnant women in kerman. J Med Council. 1995;13:322-8.
  • 15. Heidari A. Seroepidemiological study of toxoplasmosis among high-school girls in Gonabad. Qom Univ Med Sci J. 2012;5(3).
  • 16. Abdi J, Shojaee S, Mirzaee A, Keshavarz H. Seroprevalence of toxoplasmosis in pregnant women in Ilam province, Iran. Iran J Parasitol. 2008;3(2):34-7.
  • 17. Assmar M, Amirkhani A, Piazak N, Hovanesian A, Kooloobandi A, Etessami R. [Toxoplasmosis in Iran. Results of a seroepidemiological study]. Bull Soc Pathol Exot. 1997;90(1):19-21. [PubMed: 9264742].
  • 18. Ghorbani M, Edrissian G, Assad N. Serological survey of toxoplasmosis in the northern part of Iran, using indirect fluorescent antibody technique. Transactions Royal Soc Trop Med Hygiene. 1978;72(4):369-71.
  • 19. Sharif M, Ziaei H, Daryani A, Ajami A. Seroepidemiological study of toxoplasmosis in intellectual disability children in rehabilitation centers of northern Iran. Res Dev Disabil. 2007;28(3):219-24. doi: 10.1016/j.ridd.2006.03.001. [PubMed: 16650733].
  • 20. Kelishadi R, Heshmat R, Motlagh ME, Majdzadeh R, Keramatian K, Qorbani M, et al. Methodology and Early Findings of the Third Survey of CASPIAN Study: A National School-based Surveillance of Students' High Risk Behaviors. Int J Prev Med. 2012;3(6):394-401. [PubMed: 22783465].
  • 21. Daryani A, Sarvi S, Aarabi M, Mizani A, Ahmadpour E, Shokri A, et al. Seroprevalence of Toxoplasma gondii in the Iranian general population: A systematic review and meta-analysis. Acta Tropica. 2014;137:185-94. doi: 10.1016/j.actatropica.2014.05.015.
  • 22. Prusa AR, Hayde M, Pollak A, Herkner KR, Kasper DC. Evaluation of the liaison automated testing system for diagnosis of congenital toxoplasmosis. Clin Vaccine Immunol. 2012;19(11):1859-63. doi: 10.1128/CVI.00489-12. [PubMed: 23015644].
  • 23. Ogle LT, Sen A, Pahlke E, Jocelyn L, Kastberg D, Roey S, et al. International Comparisons in Fourth-Grade Reading Literacy: Findings from the Progress in International Reading Literacy Study (PIRLS) of 2001. 2003.
  • 24. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol. 2001;154(4):357-65. [PubMed: 11495859].
  • 25. Ayi I, Edu SA, Apea-Kubi KA, Boamah D, Bosompem KM, Edoh D. Sero-epidemiology of toxoplasmosis amongst pregnant women in the greater accra region of ghana. Ghana Med J. 2009;43(3):107-14. [PubMed: 20126322].
  • 26. Aspock H, Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scandinavian J Infect Dis Suppl. 1992:32.
  • 27. Studenicova C, Ondriska F, Holkova R. [Seroprevalence of Toxoplasma gondii among pregnant women in Slovakia]. Epidemiol Mikrobiol Imunol. 2008;57(1):8-13. [PubMed: 18318393].
  • 28. Jaqueti J, Hernandez-Garcia R, Nicolas D, Martinez-Hernandez D, Navarro-Gallar F, Garcia-Esteban RJ. [Serology against Toxoplasma gondii in pregnant women. Development of prevalence rates in the course of 4 years]. Rev Clin Esp. 1991;188(6):278-80. [PubMed: 1780527].
  • 29. Akyar I. Seroprevalence and Coinfections of Toxoplasma gondii in Childbearing Age Women in Turkey. Iran J Public Health. 2011;40(1):63-7. [PubMed: 23113056].
  • 30. Fuente MC, Bovone NS, Cabral GE. [Prophylaxis of prenatal toxoplasmosis]. Medicina (B Aires). 1997;57(2):155-60. [PubMed: 9532825].
  • 31. Fuente MC, Bovone NS, Cabral GE. Profilaxis de la toxoplasmosis prenatal. Medicina (Buenos Aires). 1997;57:155-60.
  • 32. Walton BC, De Arjona I, Benchoff BM. Relationship of Toxoplasma antibodies to altitude. Am J Trop Med Hyg. 1966;15(4):492-5. [PubMed: 5328733].
  • 33. Ades AE, Parker S, Gilbert R, Tookey PA, Berry T, Hjelm M, et al. Maternal prevalence of Toxoplasma antibody based on anonymous neonatal serosurvey: a geographical analysis. Epidemiol Infect. 1993;110(1):127-33. [PubMed: 8432316].
  • 34. Saffar MJ, Ajami A. Prevalence of toxoplasma gondi in pregnancy in Sari 1376-1377. J Mazandaran Univ Med Sci. 1999;9(24):1-5.
  • 35. Foroutan-Rad M, Khademvatan S, Majidiani H, Aryamand S, Rahim F, Malehi AS. Seroprevalence of Toxoplasma gondii in the Iranian pregnant women: A systematic review and meta-analysis. Acta Trop. 2016;158:160-9. doi: 10.1016/j.actatropica.2016.03.003. [PubMed: 26952970].
  • 36. Gyang VP, Akinwale OP, Lee YL, Chuang TW, Orok A, Ajibaye O, et al. Toxoplasma gondii infection: seroprevalence and associated risk factors among primary schoolchildren in Lagos City, Southern Nigeria. Rev Soc Bras Med Trop. 2015;48(1):56-63. doi: 10.1590/0037-8682-0310-2014. [PubMed: 25860465].
  • 37. Yentur Doni N, Simsek Z, Gurses G, Yildiz Zeyrek F, Demir C. Prevalence and associated risk factors of Toxoplasma gondii in female farmworkers of southeastern Turkey. J Infect Dev Ctries. 2015;9(1):87-93. doi: 10.3855/jidc.5824. [PubMed: 25596576].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments